[METRIC]
A-A-53548
23 March 1993
SUPERSEDING
A-A-0053548 (DM)
01 August 1988
COMMERCIAL ITEM DESCRIPTION
CIPROFLOXACIN TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics.
Shall be Ciprofloxacin Tablets, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
Strength:
For Strength 1, shall contain sufficient Ciprofloxacin Hydrochloride equivalent to 250 mg of Ciprofloxacin within the applicable assay limits for the tablets.
For Strength 2, shall contain sufficient Ciprofloxacin Hydrochloride equivalent to 500 mg of Ciprofloxacin within the applicable assay limits for the tablets.
For Strength 3, shall contain sufficient Ciprofloxacin Hydrochloride equivalent to 750 mg of Ciprofloxacin within the applicable assay limits for the tablets.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business